BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luan Y, Kong X, Feng Y. Mesenchymal stem cells therapy for acute liver failure: Recent advances and future perspectives. Liver Research 2021;5:53-61. [DOI: 10.1016/j.livres.2021.03.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Abdolmohammadi K, Mahmoudi T, Alimohammadi M, Tahmasebi S, Zavvar M, Hashemi SM. Mesenchymal stem cell-based therapy as a new therapeutic approach for acute inflammatory diseases. Life Sciences 2022. [DOI: 10.1016/j.lfs.2022.121206] [Reference Citation Analysis]
2 Parvanak M, Mostafavi-Pour Z, Soleimani M, Atashi A, Arefian E, Esmaeili E. Mir-122 upregulation and let-7f downregulation combination: The effects on hepatic differentiation of hiPSCs on the PCL-Gel-HA nanofibrous scaffold. J Cell Mol Med 2022. [PMID: 36098216 DOI: 10.1111/jcmm.17552] [Reference Citation Analysis]
3 Najimi M, Haider KH. Extracellular Vesicles-Based Cell-Free Therapy for Liver Regeneration. Handbook of Stem Cell Therapy 2022. [DOI: 10.1007/978-981-19-2655-6_9] [Reference Citation Analysis]
4 Najimi M, Khawaja H. Extracellular Vesicles-Based Cell-Free Therapy for Liver Regeneration. Handbook of Stem Cell Therapy 2022. [DOI: 10.1007/978-981-16-6016-0_9-1] [Reference Citation Analysis]
5 Rastogi Verma S, Yadav S, Luthra R. Therapeutic applications of mesenchymal cells derived from human placenta: A comprehensive meta-review. NeuroPharmac J 2021. [DOI: 10.37881/1.637] [Reference Citation Analysis]